Search | IOVS | ARVO Journals

Showing 1 – 20 of 37

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Bioanalytical solutions and immunogenicity challenges of species-matched antibodies in preclinical studies while investigating protein-loaded long-acting intravitreal delivery technologies

Kelly Loyet; Hilda Hernandez-Barry; Kathy Barrett; Mauricio Maia; Yanqiu Liu; Hanine Rafidi; Danielle Mandikian; Andy Boswell; Joyce Chan; Laetitia Comps-Agrar; Susan Ritger Crowell; Steven Laing; Amin Famili; Whitney Shatz-Binder; Devin Tesar; Robert Kelley

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3785.

ARVO Imaging in the Eye Conference Abstract June 2023

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Antonio MARCELO BARBANTE Casella; Raphaela M Fuganti; Luiz Lima; Ahmad Mansour; Michel Farah; Mauricio Maia; Luis Roisman; Francisco Rodriguez; Juliana Prazeres; Jose Ignacio Fernández-Vigo; Suthasinee Sinawat; Jay Chhablani; Lorenzo López-Guajard; Igor Kozak; A Osman Saatci; Stephen Schwartz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0044.

ARVO Annual Meeting Abstract June 2023

Development of IL-33/ST2 pathway activity biomarkers and their evaluation in patients with geographic atrophy secondary to AMD

Vahan Indjeian; Hsu-Hsin Chen; Luz Orozco; Ainhoa Echeverria; Trung Nguy; Ling Ma; Randall Dere; Mauricio Maia; Jennifer Hoffman; Simon S. Gao; Cheryl Schofield

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2718.

ARVO Annual Meeting Abstract June 2022

Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab

Murtaza Adam; Laura Barras; Mauricio Maia; Shamika Gune; Katie Maass; Michael Chang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4285.

ARVO Annual Meeting Abstract June 2021

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Han Ting Ding; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):350.

ARVO Annual Meeting Abstract June 2021

Immunogenicity profile of the Port Delivery System with ranibizumab in patients with nAMD

Margaret Chang; Katie Maass; Galin Jackson Spicer; Natasha Singh; Steven Blotner; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):227.

ARVO Annual Meeting Abstract June 2020

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1157.

ARVO Annual Meeting Abstract June 2020

Effect of weight-adjusted coffeine and propranolol, alone and combined, on simulated surgical skills

Marina Roizenblatt; Vitor Dias Gomes; Alex Treiger Grupenmacher; Felipe Muralha; Muller Gonçalves Urias; Jean Faber; Kim Jiramongkolchai; Peter L Gehlbach; Michel Eid Farah; Rubens Belfort Jr.; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3701.

ARVO Annual Meeting Abstract June 2020

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

Vladimir Bantseev; Joshua Horvath; Giulio Barteselli; Shrirang Ranade; Maia Mauricio; Daniela Bumbaca; Chris Schuetz; Amy Shelton; Helen Booler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2966.

ARVO Annual Meeting Abstract July 2019

Safety and retinal toxicity of a biodegradable scaffold for stem cells derived RPE implantation.Preclinical study in rabbits.

Mariana Kawamuro; rodrigo antonio brant fernandes; mauricio maia; Fernando Lojudice

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2879.

Letters to the Editor August 2018

Comments on Assays Used to Measure VEGF in the Presence of Anti-VEGF Therapeutics

PDF

Eric Wakshull; Robert Avery; Mauricio Maia
TAGS: anti-vascular endothelial growth factor therapy, therapeutics, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4106. https://doi.org/10.1167/iovs.18-24792

ARVO Annual Meeting Abstract July 2018

Intravitreal Dexamethasone Implant Migration into the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group

Mariana Batista Gonçalves; Bruno Queiroz Alves; Raphael Moura; Octaviano Magalhães Júnior; André Maia; Rubens Belfort Jr; Marcos Ávila; Marcelo Zas; Mario J Saravia; Marcia Lousas; Lihteh Wu; J Fernando Arevalo; Katia Delalibera Pacheco; Michel Eid Farah; Francisco J Rodriguez; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):390.

ARVO Annual Meeting Abstract July 2018

Combined Femtosecond Laser-Assisted Cataract Surgery and Small-Gauge Pars Plana Vitrectomy Using Different Devices: A New Trend for Vitreoretinal Surgery?

Bruno Queiroz Alves; Oswaldo Ferreira Moura Brasil; Cristiano Toesca Espinhosa; Ricardo Miguel Japiassu; Mariana Batista Gonçalves; Octaviano Magalhães Júnior; André Maia; Emmerson Badaró Cardoso; Paula Serraino; Arturo Alezzandrinni; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5921.

ARVO Annual Meeting Abstract June 2017

Influence of charge, hydrophobicity, and hydrodynamic radius on vitreous pharmacokinetics of large molecules

Susan Crowell; Kathryn Wang; Leslie Dickmann; C. Andrew Boswell; Daniela Bumbaca Yadav; Mauricio Maia; Whitney Shatz; Amin Famili; Karthik Rajagopal; Devin Tesar; Robert F. Kelley

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3600.

ARVO Annual Meeting Abstract September 2016

TWELVE-MONTH FOLLOW-UP OF DEXAMETHASONE IMPLANTS FOR MACULAR EDEMA FROM VARIOUS DISEASES IN VITRECTOMIZED AND NON-VITRECTOMIZED EYES: RESULTS FROM THE PAN AMERICAN COLLABORATIVE RETINA STUDY GROUP

Renata Tiemi Kato; Eduardo Amorim Novais; Mauricio Maia; Paulo Augusto de Mello Filho; Joao Rafael de Oliveira Dias; Marcos Avila; Andre Maia; J Fernando Arevalo; Lihteh Wu; Maria H Berrocal; Michel Farah

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4151.

ARVO Annual Meeting Abstract September 2016

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up

J Fernando Arevalo; Andres Lasave; Lihteh Wu; Mauricio Maia; Manuel Diaz-Llopis; Arturo Alezzandrini; Miguel Brito

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Functional and anatomical outcomes in patients submitted to panretinal photocoagulation using 577nm multispot vs 532nm single-spot laser: a clinical trial

José Belúcio-Neto; Camilla de Oliveira Xavier; Joao Rafael de Oliveira Dias; Renato Magalhaes Passos; Mauricio Maia; Andre Maia

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5856.

Physiology and Pharmacology October 2015

Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein Therapeutics

PDF

Leslie J. Dickmann; Victor Yip; Cuiwen Li; Juan Abundes, Jr; Mauricio Maia; Cynthia Young; Shannon Stainton; Philip E. Hass; Sean B. Joseph; Saileta Prabhu; C. Andrew Boswell
TAGS: enzyme-linked immunosorbent assay, fluorophotometry, ranibizumab, therapeutic protein, vitreous body, pharmacokinetics
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6991-6999. https://doi.org/10.1167/iovs.15-17457

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Trypan Blue free DMEK: Use of Brilliant Blue combined with Lutein / Zeaxanthin for staining of Descemet’s membrane during DMEK surgery

Bjoern O Bachmann; Sara Homem Sousa; Mario Matthaei; Claus Cursiefen; Sebastian E Siebelmann; Claudia Sa e Cunha; Diogo Sousa-Martins; Acacio Lima; Rubens Belfort; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1589.

Retinal Cell Biology March 2015

Comparing the Mode of Action of Intraocular Lutein-Based Dyes With Synthetic Dyes

PDF

Diogo Sousa-Martins; Luciano Caseli; Mafalda C. Figueiredo; Claudia Sa e Cunha; Helder Mota-Filipe; Acácio Souza-Lima; Rubens Belfort, Jr; Eduardo Rodrigues; Mauricio Maia
TAGS: dyes, lutein, tissue membrane
Invest. Ophthalmol. Vis. Sci.. 2015; 56(3):1993-2000. https://doi.org/10.1167/iovs.14-16187

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Bioanalytical solutions and immunogenicity challenges of species-matched antibodies in preclinical studies while investigating protein-loaded long-acting intravitreal delivery technologies

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Development of IL-33/ST2 pathway activity biomarkers and their evaluation in patients with geographic atrophy secondary to AMD

Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Immunogenicity profile of the Port Delivery System with ranibizumab in patients with nAMD

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Effect of weight-adjusted coffeine and propranolol, alone and combined, on simulated surgical skills

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

Safety and retinal toxicity of a biodegradable scaffold for stem cells derived RPE implantation.Preclinical study in rabbits.

Comments on Assays Used to Measure VEGF in the Presence of Anti-VEGF Therapeutics

Intravitreal Dexamethasone Implant Migration into the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group

Combined Femtosecond Laser-Assisted Cataract Surgery and Small-Gauge Pars Plana Vitrectomy Using Different Devices: A New Trend for Vitreoretinal Surgery?

Influence of charge, hydrophobicity, and hydrodynamic radius on vitreous pharmacokinetics of large molecules

TWELVE-MONTH FOLLOW-UP OF DEXAMETHASONE IMPLANTS FOR MACULAR EDEMA FROM VARIOUS DISEASES IN VITRECTOMIZED AND NON-VITRECTOMIZED EYES: RESULTS FROM THE PAN AMERICAN COLLABORATIVE RETINA STUDY GROUP

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up

Functional and anatomical outcomes in patients submitted to panretinal photocoagulation using 577nm multispot vs 532nm single-spot laser: a clinical trial

Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein Therapeutics

Trypan Blue free DMEK: Use of Brilliant Blue combined with Lutein / Zeaxanthin for staining of Descemet’s membrane during DMEK surgery

Comparing the Mode of Action of Intraocular Lutein-Based Dyes With Synthetic Dyes

To View More...

You must be signed into an individual account to use this feature.